Literature DB >> 8893510

Fertilization and development of frozen-thawed germinal vesicle bovine oocytes by a one-step dilution method in vitro.

T Suzuki1, A Boediono, M Takagi, S Saha, C Sumantri.   

Abstract

The objective of this study was to evaluate in vitro fertilization and cleavage rates of frozen-thawed bovine oocytes at the germinal vesicle (GV) stage. In mouse oocytes, spindle microtubule reorganization after GV breakdown is particularly sensitive to cold and readily damaged by exposure to low temperatures, the damage becoming apparent only at the time of the first mitotic division. The effects of various permeating cryoprotective agents [1.8 M ethylene glycol (EG), 1.3 M ethylene glycol monomethyl ether (EME), and 1.6 M 1,2-propanediol (PROH)] and different concentrations of trehalose (T) and polyvinylpyrrolidone (PVP) on post-thaw developmental capacity were examined. When bovine GV oocytes were frozen slowly in mixtures of 1.8 M EG plus 5% PVP and 0.05 M T, almost 80% developed to metaphase II; 22.2% degenerated after in vitro maturation, and none of those that had been cryopreserved underwent parthenogenetic activation. The total fertilization rate was higher (P < 0.05) for oocytes frozen in a mixture of 1.8 M EG plus 0.05 M T or 0.1 M T than in a mixture of 1.8 M EG with or without 0.2 M T; however, there was no difference in the number of normally fertilized or polyspermic oocytes that had been frozen in various cryoprotective solutions. No significant difference was observed in subsequent development using EG, EME, and PROH for GV oocytes. The addition of 0.05 or 0.1 M trehalose to the freezing solution yielded significantly better cleavage and blastocyst rates than the solutions containing 0.2 M or no trehalose. For unfrozen controls, GV oocytes yielded significantly higher (P < 0.01) cleavage and blastocyst rates compared with frozen-thawed GV oocytes. It was found that 5% PVP had a beneficial effect compared with 10 or 20% concentrations for the development of blastocysts. Transfer of six blastocysts derived from frozen-thawed GV oocytes into three recipient heifers resulted in three pregnancies and the birth of one set of twins and one singleton calf.

Entities:  

Mesh:

Year:  1996        PMID: 8893510     DOI: 10.1006/cryo.1996.0055

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  6 in total

1.  Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes.

Authors:  Katie M Lowther; Vanessa N Weitzman; Donald Maier; Lisa M Mehlmann
Journal:  Biol Reprod       Date:  2009-03-18       Impact factor: 4.285

Review 2.  Cryopreservation and in vitro maturation of germinal vesicle stage oocytes of animals for application in assisted reproductive technology.

Authors:  Ken-Ichi Yamanaka; Nobuya Aono; Hiroaki Yoshida; Eimei Sato
Journal:  Reprod Med Biol       Date:  2007-05-14

3.  Advances in the cryopreservation of mammalian oocytes and embryos: Development of ultrarapid vitrification.

Authors:  Magosaburo Kasai
Journal:  Reprod Med Biol       Date:  2002-05-16

4.  Live birth from slow-frozen rabbit oocytes after in vivo fertilisation.

Authors:  Estrella Jiménez-Trigos; José S Vicente; Francisco Marco-Jiménez
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

5.  Melatonin Improves In Vitro Development of Vitrified-Warmed Mouse Germinal Vesicle Oocytes Potentially via Modulation of Spindle Assembly Checkpoint-Related Genes.

Authors:  Zhenzheng Wu; Bo Pan; Izhar Hyder Qazi; Haoxuan Yang; Shichao Guo; Jingyu Yang; Yan Zhang; Changjun Zeng; Ming Zhang; Hongbing Han; Qingyong Meng; Guangbin Zhou
Journal:  Cells       Date:  2019-08-30       Impact factor: 6.600

Review 6.  Resurrecting biodiversity: advanced assisted reproductive technologies and biobanking.

Authors:  Rhiannon L Bolton; Andrew Mooney; Matt T Pettit; Anthony E Bolton; Lucy Morgan; Gabby J Drake; Ruth Appeltant; Susan L Walker; James D Gillis; Christina Hvilsom
Journal:  Reprod Fertil       Date:  2022-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.